Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): Comparison with state-of-the-art computed tomography (CT)

Magnetic Resonance Imaging

Volumn 14, Issue 1, 1996, Pages 43-49

  Johnson, William K ^a,c   Stoupis, Christophoros ^d   Torres, Gladys M ^a   Rosenberg, Eugene B ^a   Ros, Pablo R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Brown Radiology Associates   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

Gastrointestinal pathology; Oral contrast agent; Superparamagnetic iron oxide

Indexed keywords

BARIUM SULFATE; CONTRAST MEDIUM; DIATRIZOATE; FERUMOXSIL; IODINATED CONTRAST MEDIUM; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GASTROINTESTINAL DISEASE; HIATUS HERNIA; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVER VARIATION; ORAL DRUG ADMINISTRATION; PANCREAS PSEUDOCYST; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; SMALL INTESTINE OBSTRUCTION;

HIATUS; SPIO;

EID: 0029989330     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0730-725X(95)02044-T     Document Type: Article

References (8)

1. Magnetic resonance imaging of the abdomen and pelvis. Council on Scientific Affairs. Report of the Panel on Magnetic Resonance Imaging. JAMA 261:420-433; 1989.
2. Saini, S.; Modic, M.T.; Hamma, B.; Hahn, P.F. Advances in contrast-enhanced MR imaging. AJR 156:235-254; 1991.
3. Saini, S. Future applications of magnetic resonance contrast agents in the abdomen. Invest. Radiol. 27(Suppl. 1): S61-S63; 1992.
4. Hahn, P.F.; Stark, D.D.; Saini, S.; Lewis, J.M.; Wittenberg, J.; Ferrucci, J.T. Ferrite particles for bowel contrast in MR imaging: Design issues and feasibility studies. Radiology 164:37-41; 1987.
5. Hahn, P.F.; Stark, D.D.; Lewis, J.M.; et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 175:695-700; 1990.
6. Lönnemark, M.; Hemingsson, A.; Bach-Gansmo, T.; et al. Superparamagnetic particles as oral contrast medium in MR imaging of malignant lymphoma. Acta Radiol. 32(Fasc. 3):232-238; 1992.
7. Niemi, P.; Katevuo, K.; Kormano, M.; Baksaas, I.; Bach-Gansmo, T.; Mäenpää, J. Superparamagnetic particles as gastrointestinal contrast agent in magnetic resonance imaging of lower abdomen. Acta Radiol. 31(Fasc. 4): 409-411; 1992.
8. Ros, P.R.; Green, W.D.; Bernardino, M.E.; Harms, S.E.; Unger, P.; Hahn, P.F.; et al. Safety and efficacy of oral superparamagnetic iron oxide. Summary of multicenter phase II/III clinical trials. Radiology 18(P):93; 1991.